Horizon Pharma (HZNP +2%) says it received Notices of Allowance from the U.S. Patent and...

|About: Horizon Pharma plc (HZNP)|By:, SA News Editor

Horizon Pharma (HZNP +2%) says it received Notices of Allowance from the U.S. Patent and Trademark Office for two applications related to Duexis ibuprofen and famotidine tablets. Duexis is for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis and to decrease the risk of developing upper gastrointestinal ulcers.